Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Most antiviral or immunomodulatory therapies investigated for use in patients with COVID-19 have failed to show any mortality benefit. Similar to the previous pandemics caused by respiratory viruses, the role and benefit of corticosteroids has been under debate in COVID-19-related pulmonary disease. In this consult, we discuss the evidence regarding the efficacy of corticosteroid use in hospitalized patients with COVID-19, including data from the first randomized controlled trial on this subject.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3949/ccjm.87a.ccc059 | DOI Listing |
Publication Analysis
Top Keywords
patients covid-19
8
steroids covid-19
4
covid-19 overview
4
overview antiviral
4
antiviral immunomodulatory
4
immunomodulatory therapies
4
therapies investigated
4
investigated patients
4
covid-19 failed
4
failed mortality
4